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Abstract
Background: Identifying the bacteria and viruses present in a complex sample is useful in disease diagnostics,
product safety, environmental characterization, and research. Array-based methods have proven utility to detect in
a single assay at a reasonable cost any microbe from the thousands that have been sequenced.
Methods: We designed a pan-Microbial Detection Array (MDA) to detect all known viruses (including phages),
bacteria and plasmids and developed a novel statistical analysis method to identify mixtures of organisms from
complex samples hybridized to the array. The array has broader coverage of bacterial and viral targets and is based
on more recent sequence data and more probes per target than other microbial detection/discovery arrays in the
literature. Family-specific probes were selected for all sequenced viral and bacterial complete genomes, segments,
and plasmids. Probes were designed to tolerate some sequence variation to enable detection of divergent species
with homology to sequenced organisms, and to have no significant matches to the human genome sequence.
Results: In blinded testing on spiked samples with single or multiple viruses, the MDA was able to correctly
identify species or strains. In clinical fecal, serum, and respiratory samples, the MDA was able to detect and
characterize multiple viruses, phage, and bacteria in a sample to the family and species level, as confirmed by PCR.
Conclusions: The MDA can be used to identify the suite of viruses and bacteria present in complex samples.
Background
For microbial surveillance and discovery based on
nucleic acids from an uncharacterized sample, sequen-
cing provides the most in-depth and unbiased informa-
tion. However, the expense and time required for
sequencing using high throughput methods such as 454
(Roche), Solexa (Illumina), or SOLiD (Life Technologies)
can make these methods prohibitive for routine use,
especially when the resources required for data proces-
sing and analysis are taken into account. Viruses at low
concentration may be missed if coverage is insufficient,
and host sequence may make up 90% or more of the
reads [1]. At the other end of the cost spectrum, PCR
assays are very fast and sensitive, but have limited capa-
city for multiplexing (to test for the presence of several
organisms simultaneously). They are also intolerant of
primer-target mismatches; this is an advantage for
detecting a microbe whose sequence is precisely known,
but a great disadvantage for discovery of novel species,
or for detecting variant strains of a known species.
Microarrays span a middle ground between sequen-
cing and PCR, offering high probe density for detection
of diverse and possibly unexpected targets, costs in the
hundreds rather than thousands of dollars per sample,
and processing times on the order of 24 hours or less.
Arrays can be designed with a combination of detection
and discovery probes, which respectively target species-
specific regions (for precise characterization of known
pathogens), or more conserved regions (to enable detec-
tion of novel organisms with some homology to pre-
viously sequenced organisms). Compared to sequencing,
microarray analysis has the disadvantage that probes
designed from known sequences are unlikely to detect
truly novel organisms lacking homology to those
sequences. However, microbial genomes are difficult and
time-consuming to characterize when they have no
similarity to known sequences, so the ability of sequen-
cing to identify novel genomes has limited practical ben-
efit in a rapid diagnostic context. * Correspondence: slezak1@llnl.gov
Global Security, Lawrence Livermore National Laboratory, Livermore, CA
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known pathogens complementary to that provided by a
functional gene array, such as the array to detect viru-
lence and antibiotic resistance gene families described in
[2]. Detection arrays can tell what organisms are pre-
sent, while functional arrays can tell what capabilities
those organisms might possess. Together these tools
may be applied to detect antibiotic resistant or virulent
pathogen variants, natural chimeras, or genetically engi-
neered organisms with unusual gene content.
Detection/discovery microarrays have proven useful in
identifying or discovering viruses with homology to
known species [3-8]. They may thus be used to guide
the selection of a subset of samples for further analysis
by sequencing. Arrays can also be applied to study clini-
cal samples for which PCR diagnostics have been unin-
formative. Often, the cause of a clinically severe
infection is unknown, complicating the decision of
whether to treat with antibiotics, antivirals, or other
therapies. With optimization, and sufficiently high
pathogen titers, we have successfully generated array
results in as little as 2 hours (unpublished data). More-
over, arrays can assist in uncovering co-infections with
more than one organism. Microbial detection arrays can
also be used to check isolate stocks and vaccines for
adventitious contaminants [9]. Finally, arrays can be
used to assess the complexity of a metagenomic sample
to determine the desired depth for sequencing, poten-
tially saving costs on low complexity samples. Microar-
rays may reveal greater diversity in complex
environmental samples than sequencing of a typical
sized clone library [10]. Until the processing time and
cost of high throughput sequencing (including data ana-
lysis) decreases enough to be feasible for large numbers
of samples at sufficient depth, microarrays will continue
to be a valuable tool.
Several groups have designed microarrays containing
probes for microbial detection, discovery, or a combina-
tion of both [3-8,10-20]. Their approaches may be dis-
tinguished according to the range of pathogens targeted,
the probe design strategy, and the array platform used.
The ViroChip discovery array was one of the first to
target a broad range of pathogens; it is best known for
its role in characterizing SARS as a coronavirus [4,5,14].
It was designed by selecting probes from regions con-
served in the same family or genus based on BLAST
nucleotide sequence similarity, so that all complete viral
genomes available when it was designed (2002) were
represented by 3 probes. Later generations of the Viro-
Chip had 5-10 probes per genome and covered a larger
set of genomes; version 3 of the array included approxi-
mately 22,000 probes. It was fabricated using spotted
oligo technology, which limits the number of probes
that can be included on one array.
Chou et al. [11] designed conserved genus probes and
species specific probes covering 53 viral families and
214 genera, requiring two probes per virus. They
empirically tested a subset of 72 probes targeting the
coronavirus, flavivirus, and enterovirus families against
pure cultures of six species, although they did not exam-
ine clinical samples.
Palacios et al. [12] built the GreeneChipPm, an array
targeting vertebrate viruses and rRNA sequences of
fungi, bacteria, and protozoa, containing approximately
30,000 probes. It is an oligonucleotide array fabricated
using the Agilent ink-jet system. Viral probes were
designed to target a minimum of three genomic regions
for each family or genus, including at least one highly
conserved region coding for polymerase or structural
proteins, and two or more variable regions. Bacterial,
fungal and protozoan probes were exclusively designed
against variable segments of rRNA genes (16S for bac-
teria, 18S for eukaryotes), flanked by highly conserved
regions, so that the target regions could be amplified
with a small number of specific PCR primers. Other
groups have followed similar strategies for bacterial
array design [10,15-17]. The lack of any similar genes
universally conserved among viruses precludes using
this approach for viral target amplification.
Similar arrays designed by the same group include the
GreeneChipVr [3] (targeting viruses only) and the
GreeneChipResp [18] (targeting respiratory pathogens).
The GreeneChipPm array successfully identified viruses
at the species level, and was used to implicate Plasmo-
dium falciparum for an unexplained death. It performed
less well with bacterial samples, because probes against
the 16S rRNA variable regions frequently cross-
hybridized across taxa, so that some bacteria could only
be identified at family or class resolution.
Array design to fit all probes to span an entire king-
dom on a single microarray demands substantial invest-
ment in probe selection algorithms. Jabado et al. [19]
developed probe design software used to target con-
served amino acid regions in viruses using profile hid-
den Markov models and motif analysis, for which
uniqueness relative to non-targets was not a considera-
tion. To our knowledge, experimental data has not yet
been published for this array. Satya et al. [20] built a
software pipeline TOFI-beta for selecting target-specific
probes that are unique relative to a database of non-
targets, without requirements for conservation within a
set of multiple targets, and illustrated its application in
silico using two bacterial genomes.
In this study we describe a comprehensive, high-
density oligonucleotide array for detection and discovery
of bacteria and viruses. The large number of features on
this array, together with an efficient probe design strat-
egy, made it possible to cover all complete bacterial and
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probes per target than previously reported array designs.
We discuss the process used for array design, and report
the results of testing the array against known mixtures
of DNA and RNA viruses, as well as a variety of clinical
(fecal, sputum, and serum) samples. We also present a
novel statistical algorithm for analysis of detection/dis-
covery arrays, which combines a predictive model of
probe hybridization with a greedy likelihood maximiza-
tion procedure to identify the combination of targets in
a complex sample that best explains the observed probe
intensity pattern.
Results
Array design
The array design process is diagrammed in Figure 1. In
designing probes for our array, we sought to balance the
goals of conservation and uniqueness, prioritizing oligo
sequences that were conserved, to the extent possible,
within the family of the targeted organism, and unique
relative to other families and kingdoms. The design pro-
cess is detailed in Methods, and summarized here.
We designed arrays with larger numbers of probes per
sequence (50 or more for viruses, 15 or more for bac-
teria) than previous arrays having only 2-10 probes per
target. The large number of probes per target was
expected to improve sensitivity, an important considera-
tion given possible amplification bias in the random
PCR sample preparation protocol, which could result in
nonamplification of genome regions targeted by some
probes [7]. All bacteria and viruses with sequenced gen-
omes available at the time we began the MDA v.1
design (spring 2007) were represented: ~38,000 virus
sequences representing ~2200 species, and ~3500 bac-
terial sequences representing ~900 species. Version 1 of
the array had only viral probes. A second version of the
array (MDA v.2) was designed using both viral and bac-
terial probes. Probes were selected to avoid sequences
with high levels of similarity to human, bacterial and
viral sequences not in the target family. Low levels of
sequence similarity across families were allowed selec-
tively, when the statistical model of probe hybridization
used in our array analysis predicted a low likelihood of
cross-hybridization.
Favoring more conserved probes within a family
enabled us to minimize the total number of probes
needed to cover all existing genomes with a high probe
density per target, enhancing the capability to identify
the species of known organisms and to detect unse-
quenced or emerging organisms. Strain or subtype iden-
tification was not a goal of probe design for this array.
Nevertheless, our ability to combine information from
multiple probes in our analysis made it possible to dis-
criminate between strains of many organisms.
T h ea r r a yd e s i g na l s oi n c o r p o r a t e das e to f2 , 6 0 0
negative control probes. These probes had sequences
that were randomly generated, but with length and GC
content distributions chosen to match those of the tar-
get-specific probes.
Modeling of probe-target hybridization
We developed a novel statistical method for detection
array analysis, by modeling the likelihood of the
observed probe intensities as a function of the combina-
tion of targets present in the sample, and performing
greedy maximization to find a locally optimal set of tar-
gets; the details of the algorithm are shown in Methods.
It incorporates a probabilistic model of probe-target
hybridization based on probe-target similarity and probe
sequence complexity, with parameters fitted to experi-
mental data from samples with known genome
sequences. To accurately determine the organism(s)
responsible for a given array result, the pattern of both
positive and negative probe signals is taken into
account. The algorithm is designed to enable quantifi-
able predictions of likelihood for the presence of multi-
ple organisms in a complex sample.
A key simplification used in this algorithm was to
transform the probe intensities to binary signal values
(“positive” or “negative”), representing whether or not
the intensity exceeds an array-specific detection thresh-
old. The threshold was typically calculated as the 99
th
percentile of the intensities of the random control
probes on the array. The outcome variables in the likeli-
hood model are the positive signal probabilities for each
probe, given the presence of a particular combination of
targets in the sample. The resulting predictions are
more robust in the presence of noisy data, since the out-
come variable is a probability rather than the actual
intensity. Discretizing the intensities also led to consid-
erable savings of computation time and resources, which
are significant for arrays containing hundreds of thou-
sands of probes.
Although one might assume that reducing intensities to
binary values means discarding valuable information, the
log intensity distribution for a typical array (Figure 2)
shows that the actual information loss is much less than
expected. The figure shows separate density curves for
three classes of probes: those with BLAST hits to one of
the known targets in the sample ("target-specific”), those
without hits ("nonspecific”), and negative controls. A ver-
tical dashed line is drawn at the 99
th percentile threshold
intensity. Log2 intensities for target-specific probes either
cluster with the control and nonspecific probes (when
they have low BLAST scores, usually), or approach the
maximum possible value (16). This occurs because detec-
tion array probes are designed for high sensitivity to low
target concentrations, so that probe intensities approach
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similarity to a target in the sample. Therefore, the infor-
mation content of a probe signal is already reduced by
saturation effects.
Certain probes were found to be more likely than
others to yield positive signals, even when the sample
on the array was known to lack any targets with
sequences complementary to them. We observed that
this nonspecific hybridization occurs more often with
probes having low sequence complexity, i.e. long homo-
polymers and tandem repeats. One measure of the com-
plexity of a probe sequence is the entropy of its trimer
frequency distribution, which we compute as described
in Methods. To study whether the sequence entropy
Eliminate matches to non-target bacterial and viral families
Download target sequences in a family
Eliminate matches to human genome
Use primer3 to select candidate probes
Filter candidates based on entropy, Tm, etc.
Calculate entropy, Unafold Tm, homodimer, hairpin, and complement ∆G
Check for sufficient number candidates for each target in pool of 
filtered candidates, and allow unfiltered candidates when not enough
Blast each candidate probe in family against target family to 
find all matches of sufficient quality for probable hybridization
Rank candidates by number targets hit (conservation)
For each target, choose probes in rank order 
(most conserved first) that hit that target 
Tabulate targets hit and current number of probes for each target
Check if all targets have desired number of probes
Yes
Done, move to next family
No Add more probes in 
conserved rank order 
for targets with 
insufficient probes
Figure 1 Array design process diagram, illustrating the probe selection algorithm described in the text.
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Page 4 of 21could be used as a predictor of nonspecific hybridiza-
tion, we selected data from nine MDA v2 arrays for
which all sample components had known genome
sequences. We selected probes with no BLAST hits to
any of the known targets, grouped them by entropy into
equal sized bins, computed the positive signal frequency
(the fraction of probes with positive signals), converted
the frequency to a log-odds value, and plotted the log-
odds against the trimer entropy, as shown in Figure 3.
We also fit a logistic regression model for the probe sig-
nal as a function of entropy; a dashed line with the
resulting slope and intercept is shown in the plot. The
figure shows that the trimer entropy is an excellent pre-
dictor of the non-specific positive signal probability, and
that probes with low entropy are more likely to give
positive signals regardless of the target sequence.
While the nonspecific probe signal probability
depends on the probe sequence only, the target-specific
signal probability was assumed to be a function of both
the probe sequence and probe-target sequence similar-
ity. To determine an appropriate set of predictors for
the specific signal probability, given the presence of a
specific target, we BLASTed the probe sequences against
our database of target genomes, obtaining the best align-
ment (if any) for each probe-target pair. We then
derived various covariates from the probe-target align-
ment, including the alignment length, number of mis-
matches, bit score, E-value, predicted melting
temperature, and alignment start and end positions. We
tested all combinations of up to three covariates, using
logistic regression to fit models to data from samples
containing known targets, and performed leave-one-out
validation to find the combination with the strongest
predictive value. The best combination included three
covariates: (1) The predicted melting temperature, com-
puted as described in Methods; (2) the BLAST bit score
and (3) the alignment start position relative to the 5’
end of the probe. We expected the alignment start posi-
tion to have a significant effect, because we observed in
our previous work [2] that probe-target mismatches had
a weaker effect on hybridization if the mismatch was
closer to the 3’ end of the probe (nearer to the array
surface).
Likelihood maximization algorithm
To find a combination of targets whose presence in the
sample best explains the observed data, we used a
greedy algorithm to find a local maximum for the log-
likelihood, as described in Methods. We can think of
the likelihood maximization algorithm as an iterative
process, in which we first find the target that explains
the largest portion of the observed positive probe sig-
nals, while minimizing the number of negative probes
that would be expected to bind to the target. In each
subsequent iteration, we choose the target that explains
the largest part of the signal not already explained by
the first target, while again minimizing the number of
expected negative probes. The process continues until a
maximal portion of the observed probe signals are
explained, or for a specified maximum number of
iterations.
10 12 14 16
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
1
.
2
Log intensity
P
r
o
b
a
b
i
l
i
t
y
 
d
e
n
s
i
t
y
 
(
s
c
a
l
e
d
)
Target specific
Nonspecific
Control
Figure 2 Intensity distributions for an MDA v.2 array
hybridized to a spiked mixture of vaccinia virus and HHV6B,
for probes with and without target-specific BLAST hits and for
negative control probes. Vertical line: 99
th percentile of negative
control distribution.
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Figure 3 Dependence of nonspecific positive signal frequency
on the trimer entropy of the probe sequences. Dashed line is a
logistic regression fit to the probe entropy and signal data.
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Page 5 of 21Probe Counts LogOdds
1478.8 438 expected
223 detected
Bovine viral diarrhea virus 1|BVI133738
Bovine viral diarrhea virus complete RNA
1443.7 430 expected
215 detected
Bovine viral diarrhea virus 1 strain Singer_Arg
1441 438 expected
222 detected
Bovine viral diarrhea virus 1SD1
polyprotein gene
1478 436 expected
223 detected
Bovine viral diarrhea virus 1
1426.8 439 expected
221 detected
Bovine viral diarrhea virus 1|Bovine viral
diarrhea virus strain Oregon C24V
1420.9 434 expected
220 detected
Bovine viral diarrhea virus 1|Pestivirus type 1
1253.7 421 expected
215 detected
Bovine viral diarrhea virus 1|Pestivirus
type 1 noncytopathic genomic RNA
1215.9 407 expected
211 detected
Bovine viral diarrhea virus 1|Pestivirus
type 1 cytopathic genomic RNA
1318 437 expected
220 detected
Bovine viral diarrhea virus 1 strain KE9
1233.9 434 expected
217 detected
Bovine viral diarrhea virus 1 strain ZM95
1303.7 437 expected
221 detected
Bovine viral diarrhea virus 1|Bovine viral
diarrhea virus VEDEVAC ORF1 for
1252.6 435 expected
218 detected
Bovine viral diarrhea virus 1|Bovine viral
diarrhea virus1
903.5 412 expected
202 detected
Bovine viral diarrhea virus 2|Bovine viral
diarrhea virus genotype 2
919.6 426 expected
203 detected
Bovine viral diarrhea virus 2New York'93
904 416 expected
201 detected
Bovine viral diarrhea virus 2| Bovine viral
diarrhea virus genotype 2 strain p11Q
889.8 422 expected
199 detected
Bovine viral diarrhea virus 2| Bovine viral
diarrhea virus genotype 2 strain p24515
643.1 856 expected
43 detected
Clostridium leptum|GF:648631
(Clostridium leptum DSM 753
623.6 916 expected
41 detected
Anaerotruncus colihominis|GF:651056
(Anaerotruncus colihominis DSM
628 1019 expected
58 detected
Clostridium scindens|GF:651069
(Clostridium scindens ATCC 35704
643.1 856 expected
43 detected
Clostridium leptum|GF:636890
(Clostridium leptum DSM 753
Viral and Bacterial Families
Flaviviridae Clostridiaceae
Figure 4 MDA v2 results for a spiked sample of bovine viral diarrhea virus. Many of the same conserved probes that hybridize to BVDV
also match classical swine fever virus and Border disease virus, although these have a lower log-odds and so are not the “detected” organism,
which is labeled in red.
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Page 6 of 21The analysis results are typically visualized as shown
i nF i g u r e s4 ,5 ,6 ,7 ,8 ,9 ,1 0 ,a n d1 1 .T h eb a rg r a p h si n
the right-hand column show the initial and final log-
odds scores for the target genomes predicted to be pre-
sent (annotated in red boldface), together with the
highest-scoring targets in the same taxonomic families
as the predicted targets. The bars are divided into light
and dark shaded sections, corresponding to the initial
and final scores respectively. Bars with the same hue
correspond to targets in the same family.
Probe Counts LogOdds
1475.7 444 expected
227 detected
Vaccinia virus strain Acambis clone 2000
1473.2 444 expected
225 detected
Vaccinia virus (strain Tian Tan) complete genome
1473.2 444 expected
225 detected
Vaccinia virus|raw sequence of Vaccinia
virus (strain Tian Tan) updated complete
1475.1 454 expected
227 detected
Vaccinia virus (strain Lister) complete
genome from CDC on Apr 13 2005 3:03PM
1473.1 448 expected
225 detected
Vaccinia virus strain Lister
1473.4 444 expected
225 detected
Vaccinia virus strain LC16m8
1473.4 444 expected
225 detected
Vaccinia virus strain LC16mO
1089.9 296 expected
143 detected
Human herpesvirus 6B DNA, strain: HST
1088.4 296 expected
141 detected
Human herpesvirus 6B
1058.6 265 expected
134 detected
Human herpesvirus 6A
741 46 expected
40 detected
Bacteriophage phiMFV1|Mycoplasma phage phiMFV1
699.6 65 expected
28 detected
Human endogenous retrovirus K115 complete genome
698.9 70 expected
28 detected
Human endogenous retrovirus K113 complete genome
616.6 858 expected
71 detected
Mariprofundus ferrooxydans|GF:632951
(Mariprofundus ferrooxydans PV1
592.1 95 expected
13 detected
candidate division TM7 isolate
TM7b|GF:636167 (candidate division
591.5 641 expected
37 detected
Candidatus Ruthia magnifica str. Cm
(Calyptogena magnifica)
593.2 1011 expected
79 detected
marine gamma proteobacterium
HTCC2143|GF:630924 (marine
601.6 952 expected
68 detected
gamma proteobacterium HTCC2207|GF:636223
(gamma proteobacterium HTCC2207 marine
601.5 952 expected
68 detected
gamma proteobacterium HTCC2207|GF:632981
(marine gamma proteobacterium HTCC2207
616.6 858 expected
71 detected
Mariprofundus ferrooxydans|GF:636226
(Mariprofundus ferrooxydans PV1
Viral and Bacterial Families
Poxviridae
Herpesviridae
nonConformingViral
Retroviridae
nonConformingBacterial
Figure 5 MDA v.2 results for a spiked mixture of vaccinia virus and HHV6B.
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Page 7 of 21The bar graphs in the left-hand column represent expec-
tation (mean) values of the positive probe counts for each
target, given the presence of the corresponding target gen-
ome. The larger “expected” score is obtained by summing
the positive signal probabilities for all probes; the smaller
“detected” score is derived by limiting this sum to probes
having positive signals. Because probes often cross-hybri-
dize to multiple related genome sequences, the numbers
of “expected” and “detected” probes may greatly exceed
t h en u m b e ro fp r o b e st h a tw e r ea c t u a l l yd e s i g n e df o ra
Probe Counts LogOdds
451.4 270 expected
87 detected
Human Respiratory syncytial virus 9320
438.8 224 expected
76 detected
Human respiratory syncytial virus sequence
from Genbank on 04/14/03 12:57
414.3 277 expected
85 detected
Human respiratory syncytial virus strain
ATCC VR26
412.5 268 expected
82 detected
Human respiratory syncytial virus S2
254.5 512 expected
50 detected
Human coronavirus HKU1 strain N25 genotype B
253.9 512 expected
50 detected
Human coronavirus HKU1 genotype B
253.3 512 expected
50 detected
Human coronavirus HKU1 strain N15 genotype B
246.6 517 expected
50 detected
Human coronavirus HKU1 strain N21 genotype C
121.5 382 expected
50 detected
 Influenza A virus (A/blackheaded
gull/Sweden/4/99(H16N3)) hemagglutinin (HA) gene
83.9 98 expected
9 detected
Influenza A virus (A/black
duck/AUS/4045/1980(H6N5)) segment 6
121.5 382 expected
50 detected
 Influenza A virus (A/blackheaded
gull/Sweden/2/99(H16N3)) hemagglutinin (HA) gene
80.4 233 expected
16 detected
 Influenza B virus (B/Memphis/13/03) PB1 (PB1)
gene
121.5 382 expected
50 detected
 Influenza A virus (A/blackheaded
gull/Sweden/3/99(H16N3)) hemagglutinin (HA) gene
111 408 expected
50 detected
 Influenza A virus (A/blackheaded
gull/Sweden/5/99(H16N3)) hemagglutinin (HA) gene
91.7 133 expected
12 detected
Leek yellow stripe potyvirus genomic RNA for
partial nuclear inclusion protein and coat
46.7 581 expected
33 detected
Pea seedborne mosaic virus complete genome
84.2 377 expected
21 detected
HIV1 isolate hypermutated VAU group O from
France
71.6 410 expected
26 detected
HIV1 isolate 98CMABB212 from Cameroon
66.8 430 expected
28 detected
Human immunodeficiency virus type 1
55.7 436 expected
20 detected
Simian immunodeficiency virus isolate
SIVcpzGAB2 complete genome
Viral and Bacterial Families
Paramyxoviridae 
Coronaviridae 
Orthomyxoviridae 
Potyviridae 
Retroviridae 
Figure 6 MDA v.1 results for a clinical induced sputum sample.
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Page 8 of 21given target organism. The probe count bar graphs are
designed to provide some additional guidance for inter-
preting the prediction results.
Testing on pure and mixed samples of known viruses
Several viruses with sequenced genomes (adenovirus type
7, respiratory syncytial virus [RSV], and bovine viral diar-
rhea virus [BVDV]) were each hybridized to MDA v.1
arrays in separate array experiments. Analysis of each
array identified the known virus as the highest scoring tar-
get (data not shown). Several mixtures of both RNA and
DNA viruses were also tested (Table 1). All spiked species
were detected in the mixture, including most of the seg-
ments of bluetongue virus (BTV). Strain discrimination
was not expected, since probes were designed from
regions conserved within viral families. Nevertheless, the
Probe Counts LogOdds
1254.9 239 expected
231 detected
Hepatitis B virus clone dzc12 from China
963.9 175 expected
168 detected
Hepatitis B virus DNA, isolate: BOL196
743.4 121 expected
120 detected
Hepatitis B virus (SUBTYPE ADW2), genotype A
400.7 73 expected
50 detected
Hepatitis B virus complete genome, isolate:IS1OY
1181.3 219 expected
214 detected
Hepatitis B virus DNA, isolate: UZNVC7M
1179.9 218 expected
213 detected
Hepatitis B virus DNA, isolate: UZNVC7
1201.4 233 expected
220 detected
Hepatitis B virus isolate TW836 genotype B
1234 237 expected
227 detected
Hepatitis B virus subtype ADW genomic
DNA, clone: pODW282
1172.8 223 expected
213 detected
Hepatitis B virus isolate BTO5856
1223.3 234 expected
224 detected
Hepatitis B virus clone dzc5 from China
1218.8 233 expected
223 detected
Hepatitis B virus clone dzc19 from China
1166.2 221 expected
212 detected
Hepatitis B virus clone 22115
1203.2 229 expected
219 detected
Hepatitis B virus clone 22042 from China
1192.7 238 expected
217 detected
Hepatitis B virus isolate PW4
1203.4 227 expected
219 detected
Hepatitis B virus isolate ph76
1150.2 234 expected
209 detected
Hepatitis B virus isolate Ran128
1197.4 248 expected
218 detected
Hepatitis B virus isolate PW3
1197 249 expected
218 detected
Hepatitis B virus isolate PW1
185.8 3664 expected
61 detected
Plesiocystis pacifica|GF:636242
(Plesiocystis pacifica SIR1
Viral and Bacterial Families
Hepadnaviridae Nannocystaceae
Figure 7 Clinical serum sample 1_5, provided by the DeRisi lab at UCSF, analyzed on MDA v.2.
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Page 9 of 21highest scoring targets in the single virus experiments with
adenovirus, BVDV, vaccinia and human herpesvirus 6B
(HHV6B) were in fact the strains hybridized to the arrays.
Human endogenous retrovirus K113 was also detected in
two of the three mixtures, possibly from host cell DNA.
For three samples tested, we compared the spiked strain
identities with those predicted by analyzing either 1) only
the LLNL probes versus 2) analyzing only the ViroChip
probes which were also included on the MDA. The LLNL
probes identified the correct Gomen strain of human
Probe Counts LogOdds
1216.6 244 expected
102 detected
Human parechovirus 1 isolate BNI788St
1171.5 234 expected
100 detected
Human parechovirus 3 genomic RNA, isolate
Can8285301
1165 238 expected
100 detected
Human parechovirus 3 genomic RNA, strain:A308/99
1159.1 235 expected
101 detected
Human parechovirus 4 isolate K25117602
1068.3 242 expected
99 detected
Human parechovirus 6 genomic RNA, strain:
NII5612000
926.3 223 expected
97 detected
Human parechovirus|Echovirus 23 strain CT866760
951.3 237 expected
101 detected
Human parechovirus, genome
1028.8 1011 expected
116 detected
Streptococcus thermophilus LMD9
918.3 44 expected
13 detected
Lactococcus lactis subsp. lactis plasmid pK214
919.2 151 expected
40 detected
Streptococcus agalactiae NEM316
complete genome, segment 3
895.2 205 expected
47 detected
Streptococcus agalactiae NEM316
complete genome, segment 1
901.8 987 expected
86 detected
Streptococcus suis|GF:630895
(Streptococcus suis 89/1591
955.8 977 expected
98 detected
Streptococcus suis 05ZYH33
936.9 1184 expected
107 detected
Streptococcus mutans UA159
954.3 979 expected
97 detected
Streptococcus suis 98HAH33
917.4 1036 expected
100 detected
Streptococcus sanguinis SK36
908 1077 expected
103 detected
Streptococcus gordonii str. Challis substr. CH1
949.2 972 expected
97 detected
Streptococcus thermophilus LMG 18311
948.2 997 expected
97 detected
Streptococcus thermophilus CNRZ1066
935.8 1507 expected
86 detected
Desulfatibacillum
alkenivorans|GF:648636
Viral and Bacterial Families
Picornaviridae Streptococcaceae Desulfobacteraceae
Figure 8 Clinical fecal sample 2_1, provided by the DeRisi lab at UCSF, analyzed on MDA v.2.
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Page 10 of 21adenovirus type 7 while the ViroChip probes identified the
correct species but the incorrect NHRC 1315 strain. In
another example, when RSV Long group A (an unse-
quenced strain) was hybridized to the array, the related
RSV strain ATCC VR-26 was predicted by MDA probes,
but the ViroChip probes failed to detect any RSV strain.
For the detection of BVDV Singer strain, both LLNL and
ViroChip probes were able to predict the exact strain
hybridized.
False negative error rates were estimated for MDA v.1
from experiments in which some or all of the viruses in
the sample had known genome sequences (Table 2), for
Probe Counts LogOdds
1477.7 1790 expected
276 detected
Escherichia coli CFT073
1365 1579 expected
214 detected
Escherichia coli E24377A
1392.5 1344 expected
229 detected
Shigella dysenteriae Sd197
1466.4 1571 expected
272 detected
Shigella flexneri 5 str. 8401
1470.8 1762 expected
276 detected
Escherichia coli 042  from Sanger on
Aug 24 2005 2:52PM
1413.6 1558 expected
237 detected
Escherichia coli HS
1388.4 1825 expected
283 detected
Escherichia coli|GF:630814
(Escherichia coli B171 Escherichia
1350.5 1831 expected
290 detected
Escherichia coli UTI89
908.5 401 expected
77 detected
Norwalk virus|Norovirus
Hu/NLV/GII/Neustrelitz260/2000/DE from Germany
898 409 expected
77 detected
Norwalk virus|Norwalklike virus genomic
RNA, isolate:Saitama U18
897.9 412 expected
76 detected
Norwalk virus|Norwalklike virus genomic
RNA, isolate:Saitama U201
891.2 425 expected
79 detected
Norwalk virus|Human calicivirus strain Mc37
934.1 415 expected
53 detected
Dehalococcoides sp. CBDB1
956.3 858 expected
84 detected
Mariprofundus ferrooxydans|GF:636226
(Mariprofundus ferrooxydans PV1
954.5 858 expected
84 detected
Mariprofundus ferrooxydans|GF:632951
(Mariprofundus ferrooxydans PV1
997.5 889 expected
97 detected
marine gamma proteobacterium
HTCC2080|GF:630923 (marine
993.7 952 expected
89 detected
gamma proteobacterium HTCC2207|GF:632981
(marine gamma proteobacterium HTCC2207
994.6 952 expected
89 detected
gamma proteobacterium HTCC2207|GF:636223
(gamma proteobacterium HTCC2207 marine
957 1129 expected
111 detected
Endoriftia persephone|GF:637262
(Endoriftia persephone
970.7 1011 expected
103 detected
marine gamma proteobacterium
HTCC2143|GF:630924 (marine
974.4 1146 expected
96 detected
Reinekea sp. MED297|GF:630868 (Reinekea
sp. MED297 Reinekea sp. MED297, unfinished
Viral and Bacterial Families
Enterobacteriaceae Caliciviridae nonConformingBacterial
Figure 9 Clinical fecal sample 2_2, provided by the DeRisi lab at UCSF, analyzed on MDA v.2.
Gardner et al. BMC Genomics 2010, 11:668
http://www.biomedcentral.com/1471-2164/11/668
Page 11 of 21probes that met our design criteria (85% identity and a
29 nt perfect match to one of the target genome
sequences). The RSV and BTV probes were excluded from
this estimate, as sequences were not available for the exact
strains used in the experiments. All 128 selected probes
had signals above the 99
th percentile detection threshold,
yielding a zero false negative error rate.
To validate MDA v.2 with known spiked viruses,
BVDV type 1 (Figure 4) and a mixture of vaccinia Lister
and HHV 6B (Figure 5) were correctly identified to the
Probe Counts LogOdds
862.8 61 expected
51 detected
Chicken anemia virus isolate 31 from Malaysia
862.6 61 expected
51 detected
Chicken anemia virus isolate AH6 from China
861.2 61 expected
51 detected
Chicken anemia virus from China
860 61 expected
51 detected
Chicken anemia virus isolate C14.~~
859.4 61 expected
51 detected
Chicken anemia virus isolate SMSC1P9WT
859.2 61 expected
51 detected
Chicken anemia virus
816 1678 expected
120 detected
Serratia proteamaculans 568
782.7 1468 expected
91 detected
Providencia stuartii|GF:649908
(Providencia stuartii ATCC 25827
802.9 1284 expected
107 detected
Sodalis glossinidius str. 'morsitans'
804.6 1579 expected
97 detected
Pectobacterium atrosepticum|Erwinia
carotovora subsp. atroseptica SCRI1043
768.7 1626 expected
128 detected
Erwinia chrysanthemi|GF:188098 (Erwinia
chrysanthemi NO STRAIN sequence from
803.8 1678 expected
121 detected
Serratia proteamaculans|GF:630880
(Serratia proteamaculans 568 Serratia
701.2 95 expected
14 detected
candidate division TM7 isolate
TM7b|GF:636167 (candidate division
717.1 858 expected
53 detected
Mariprofundus ferrooxydans|GF:636226
(Mariprofundus ferrooxydans PV1
721.5 1129 expected
68 detected
Endoriftia persephone|GF:637262
(Endoriftia persephone
722 1011 expected
60 detected
marine gamma proteobacterium
HTCC2143|GF:630924 (marine
744.4 952 expected
64 detected
gamma proteobacterium HTCC2207|GF:632981
(marine gamma proteobacterium HTCC2207
744.4 952 expected
64 detected
gamma proteobacterium HTCC2207|GF:636223
(gamma proteobacterium HTCC2207 marine
739.9 889 expected
67 detected
marine gamma proteobacterium
HTCC2080|GF:630923 (marine
Viral and Bacterial Families
Circoviridae Enterobacteriaceae nonConformingBacterial
Figure 10 Clinical fecal sample 2_3, provided by the DeRisi lab at UCSF, analyzed on MDA v.2.
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Page 12 of 21species level. Virus sequences selected as likely to be
present are highlighted in red in these figures. On the
vaccinia+HHV 6B array, human endogenous retrovirus
K113 was also detected. In addition, several organisms
that were unlikely to be present were predicted,
probably because of non-specific probe binding or
cross-hybridization. These organisms, Mariprofundus
ferrooxydans (a deep sea bacterium collected near
Hawaii), candidate division TM7 (collected from a sub-
gingival plaque in the human mouth), and marine
Probe Counts LogOdds
1676.6 1788 expected
319 detected
Staphylococcus aureus subsp. aureus Mu50
900.5 43 expected
19 detected
Staphylococcus aureus subsp. aureus
USA300_TCH959 plasmid pUSA300HOUMS
1676.5 1788 expected
319 detected
Staphylococcus aureus subsp. aureus Mu3
1585.2 1828 expected
317 detected
Staphylococcus aureus subsp. aureus str. Newman
1556.6 1344 expected
235 detected
Shigella dysenteriae Sd197
1053.7 107 expected
55 detected
Escherichia coli plasmid pAPECO2ColV
890.7 33 expected
16 detected
Shigella sonnei Ss046 plasmid pSS046_spB
1544.2 1790 expected
264 detected
Escherichia coli CFT073
1542.2 1417 expected
246 detected
Shigella dysenteriae|GF:447836 (Shigella
dysenteriae M131649 from Sanger on Aug
1241.9 1036 expected
167 detected
Streptococcus sanguinis SK36
935.1 61 expected
29 detected
Lactococcus lactis plasmid pGdh442
877.8 14 expected
11 detected
Lactococcus lactis subsp. lactis plasmid pCI305
877.6 16 expected
10 detected
Lactococcus lactis plasmid pSRQ800
1252.7 972 expected
170 detected
Streptococcus thermophilus LMG 18311
1251.8 997 expected
170 detected
Streptococcus thermophilus CNRZ1066
1282.6 1011 expected
182 detected
Streptococcus thermophilus LMD9
1232.6 160 expected
118 detected
Staphylococcus aureus temperate
phage phiSLT|Staphylococcus phage phiSLT
1215.7 145 expected
98 detected
Staphylococcus aureus bacteriophage
PVL|Staphylococcus prophage PVL
1244.5 177 expected
114 detected
Staphylococcus aureus phage
phiNM|Staphylococcus phage phiNM
865.2 28 expected
12 detected
Enterococcus faecalis V583 plasmid pTEF3
1092 1450 expected
180 detected
Enterococcus faecalis V583
Viral and Bacterial Families
Staphylococcaceae
Enterobacteriaceae
Streptococcaceae
Siphoviridae
Enterococcaceae
Figure 11 Clinical fecal sample 2_4, provided by the DeRisi lab at UCSF, analyzed on MDA v.2.
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Page 13 of 21gamma-proteobacterium (collected in the coastal Pacific
Ocean at 10 m depth) were detected with low log-odds
scores on numerous experiments using different samples.
Genome sequences for these were not included in the
probe design because they became available only after we
designed the microarray probes or because they were not
classified into a bacterial taxonomic family; therefore
probes were not screened for cross-hybridization against
these targets. However, these sequences were included in
the analysis database, since this database included
sequences not classified as to bacterial family and it was
compiled a few months after the probes were designed.
Genome comparisons indicate that M. ferrooxydans,
TM7b, and marine gamma proteobacterium HTCC2143
share 70%, 55%, and 61%, respectively, of their sequence
with other bacteria and viruses, based on simply consid-
ering every oligo of size at least 18 nt also present in
other sequenced viruses or bacteria, so many of the
probes designed for other organisms may also hybridize
to these targets.
Testing on Blinded Samples from Pure Culture
Blinded samples were provided from collaborator Robert
Tesh at UTMB for 11 viruses. We hybridized each of
those samples separately to MDA v.2 and predicted the
identities of each virus (Table 3). Ten of 11 of the spe-
cies predicted by the MDA were confirmed by Dr. Tesh.
In addition, endogenous retroviruses were also detected
in 7 of the samples as well as the uninfected Vero cell
control, indicating the presence of host DNA from the
culture cells. These included one or more of the follow-
ing: Baboon endogenous virus strain M7 and human
endogenous retroviruses K113, K115, and HCML-ARV,
with human endogenous retrovirus K113 being the most
c o m m o n .T h eo n es a m p l et h a tw ef a i l e dt od e t e c to n
the array was vesicular stomatitis virus, NJ (VSV NJ).
We confirmed that it was present in the sample using
two proprietary, unpublished TaqMan assays developed
by colleagues at LLNL and tested by LLNL colleagues at
Plum Island that specifically detect VSV NJ. There were
no complete genomes of VSV NJ available. Conse-
quently, we designed no probes for this species. Nor
was it included in our database for the statistical ana-
lyses. It is sufficiently different from the genomes avail-
able for VSV Indiana that none of those probes had
BLAST similarity to the partial sequences available for
VSV NJ. There were 7 probes from the ViroChip corre-
sponding to VSV NJ that were detected. These probes
were designed from partial sequences [4].
Detection of viruses and bacteria from clinical samples
We tested a clinical induced sputum sample provided to
us by the UCSF DeRisi lab on MDA v.1 (Figure 6), and
detected human respiratory syncytial virus and human
Table 1 Results of initial tests on MDA v.1
Mixture tested Detected Additionally detected
Adenovirus type 7 strain Gomen Yes Human endogenous retrovirus K113
Respiratory syncytial virus strain Long Yes Leek yellow stripe potyvirus
Bovine viral diarrhea virus type 1 strain Singer Yes
Respiratory syncytial virus strain B1 Yes None
Bluetongue virus type 2 Yes (segments 2,6,8,9,10)
Human herpesvirus 6B Yes Human endogenous retrovirus K113
Vaccinia virus strain Lister Yes Influenza A segment 8
Respiratory syncytial virus strain B1 Yes
Bluetongue virus type 2 Yes (segments 2,6,7,8,9,10)
Table 2 True positive/false negative counts for probes in MDA v.1 tests with sequenced viruses
Target Number of perfect match probes TP probes FN probes Percent FN error rate
Pure viral cultures:
Adenovirus type 7 Gomen 52 52 0 0.0
Bovine viral diarrhea virus (BVDV) 25 25 0 0.0
Mixture of viral cultures:
Human herpesvirus 6B 14 14 0 0.0
Vaccinia virus Lister strain 37 37 0 0.0
Total 51 51 0 0.0%
Overall 128 128 0 0.0%
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Page 14 of 21coronavirus HKU1. We confirmed the results using spe-
cific PCR for these two viruses (Additional file 1). The
results were also confirmed by the DeRisi lab using the
ViroChip. The MDA results indicated small log-odds
scores for influenza A, leek yellow stripe potyvirus, and
HIV-1, although these low scores are a result of just a
few probes and are likely due to nonspecific binding
rather than true positives. Other samples tested using
MDA v.1 also had low scoring predictions for Influenza
A and Leek yellow stripe potyvirus (see Table 1), which
we suspect were due to non-specific binding.
Closer examination of probes giving high signal inten-
sities that were not consistent with the “detected” organ-
isms showed that there were some “sticky” probes that
seemed to bind non-specifically. On the MDA v.2 array,
we noted that 141 probes were detected in a majority
(31 out of 60) of arrays hybridized to a wide variety of
sample types. A small number of these probes were
found to have significant BLAST hits to the human gen-
ome. Since most of the samples tested on the array
were either human clinical samples or were grown in
Vero cells (an African green monkey cell line), the fre-
quent high signals for these few probes can be explained
by the presence of primate DNA in the sample. The
vast majority of sticky probes, however, were not
explained by cross-hybridization to host DNA. We did
note significant differences between sticky and non-
sticky probes in the distributions of trimer entropy and
hybridization free energy; sticky probes had smaller
entropies (mean 4.6 vs 4.8 bits, p=7 . 5×1 0
-14)a n d
more negative free energies (mean -70.5 vs -66.8 kcal/
mol, p =3 . 8×1 0
-13)c o m p a r e dt o1 7 5 5n o n - s t i c k y
probes detected in 11 or fewer samples. Consequently,
in v.2 of the chip design, we imposed an entropy filter
as described in the methods, and additionally designed
more probe sequences at the expense of the number of
replicates per probe.
We tested partially amplified clinical samples provided
by Joe DeRisi’s laboratory at UCSF on MDA v.2. The
source (e.g. fecal or serum) was blinded during our ana-
lyses, but was provided later: sample 1_5 from serum
(Figure 7), and the rest from fecal sources (Figures 8, 9,
10, and 11). No patient history was provided. A strong
signal indicating the presence of hepatitis B virus was
detected in sample 1_5 (Figure 7). In all the remaining
samples, signals were detected for a mixture of both
viruses and bacteria, many of which are known to be
associated with gastrointestinal distress. All of the
organisms detected by the array were confirmed by PCR
except Serratia proteamaculans in sample 2_3 and the
E. coli pAPEC O2-ColV plasmid in sample 2_4 (Addi-
tional file 1) In some cases, multiple species in a genus
have similarly high log-odds ratios, suggesting that a
member of that genus is like l yt ob ep r e s e n t ,b u tt h e
MDA cannot make a definitive call as to which species.
For example, signals for multiple Streptococcus species
were detected in sample 2_1 (Figure 8). We expect that
this pattern could arise in cases where a novel unse-
quenced isolate from the genus is present, in cases
where conservation at the genus level is sufficiently high
that the conserved probes do not provide species discri-
mination, or when multiple related organisms are pre-
sent. Since the probes were selected from conserved
regions within a family, the array was not designed for
stringent species or strain discrimination. In sample 2_3
(Figure 10) we saw a strong signal for the presence of
chicken anemia virus which was confirmed by PCR.
This circovirus infects chickens, pointing to a dietary
influence on the components of this human fecal sam-
ple. It is similar to the recently discovered and wide-
spread human TT virus and TTV-like mini virus
(TLMV) [21]. Other studies have also found viruses
from food in fecal samples [22]. Phage are also com-
monly detected in feces, particularly when sample pre-
paration enriches for phage, for example, by purification
Table 3 Results of blinded testing on viral isolate samples from Robert Tesh at University of Texas, Medical Branch
ID Culture results Array results
— Vero cells not infected Background signal
TVP-11180 Punta Toro Punta Toro virus strain Adames
TVP-11181 Thogoto Thogoto virus strain IIA
TVP-11182 Dengue 4 Dengue 4 strain ThD4_0734_00
TVP-11183 CTF Colorado tick fever virus
TVP-11184 Cache Valley Cache Valley genome RNA for N and NSs proteins
TVP-11185 Ilheus Ilheus virus
TVP-11186 EHD-NJ Epizootic hemorrhagic disease virus isolate 1999_MS-B NS3
TVP-11187 La Crosse La Crosse virus strain LACV
TVP-11188 SF Sicilian Sandfly fever Sicilian virus
TVP-11189 VSV-NJ Not detected
TVP-11191 Ross River Ross River virus
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Page 15 of 21in a cesium chloride gradient [23]. We did not do any
gradient purification for phage enrichment, and
although we detected more signals from bacteria than
from the bacteriophage that infect those bacteria, we did
detect signals for Staphylococcus aureus phage as the
viral component of sample 2_4, as well as signals that
its host bacteria was present (Figure 11).
Discussion
We report on a high density oligo microarray and statis-
tical analysis method that has detected viral and bacter-
ial sequences from single DNA and RNA viruses and
mixtures thereof, various clinical samples, and blinded
cell culture samples provided to us by our collaborators.
Results from clinical samples were validated using PCR.
The MDA v.2 has higher probe density and larger phy-
logenetic representation of viral and bacterial sequenced
genomes than other published array designs. It can be
applied to problems in viral and bacterial detection from
pure or complex environmental or clinical samples. It
may be particularly useful to widen the scope of search
for microbial identification when specific PCR fails, as
well as to identify co-infecting organisms.
The analysis method described here differs in several
key ways from previous statistical approaches to analyze
microbial detection arrays, such as E-Predict [24] and
GreeneLAMP [12]. E-Predict compares a probe intensity
vector for each array against a theoretical hybridization
free energy vector for each sequence in a target data-
base, both normalized to unit length, using the Pearson
correlation coefficient. Significance values are assigned
to the correlation scores by comparing them against an
empirical distribution derived from over 1,000 array
experiments. To handle samples that may contain a
mixture of organisms, there is an iterative version of
E-Predict, which, after identifying the most likely target
on an array, sets the intensities of the probes matching
the target to zero, computes new correlation coefficients,
and repeats the identification process. Since it requires a
corpus of data from previous experiments with the same
array design, E-Predict cannot be applied to new, proto-
type array designs. E-Predict also has limited applicability
to complex samples, in which several closely related
strains of the same species may be present.
The GreeneLAMP algorithm [12] assigns probes to
target taxa using BLAST alignments, and computes a
p-value for each probe intensity by performing a z-test
against a log-normal distribution. Intensities are first
background-corrected, using data from a matched con-
trol array when available, or random control probes on
the same array otherwise. The parameters of the distri-
bution are inferred from the intensities of all probes on
the array, under the assumption (usually justified) that
only a small fraction of probes will hybridize to the
target on the array. Probes are categorized as positive or
negative by comparing their p-values against a fixed
threshold. The p-values for the positive probes asso-
ciated with each taxon are then multiplied, and an
aggregate p-value computed for the product, using the
method of Bailey [25]. Finally, candidate taxa are ranked
by the aggregate p-value. The GreeneLAMP method
depends heavily on the assumption that probe intensities
are independent measurements of target genome abun-
dances, which is not always justified. An iterative version
of the method has not been reported to date; this makes
it inappropriate for identifying mixtures of organisms in
a sample, since the output of the algorithm is a single
ranked list of taxa
The MDA array design and accompanying analysis
algorithm have been found to perform well in identify-
ing mixtures of known pathogens. In cases where a sam-
ple contains an organism that has not been sequenced
(or whose sequence is not in our analysis database), but
is sufficiently similar to other sequenced microbes, the
analysis will identify multiple related organisms most
similar to the one in the sample. Similar results will be
seen when the sample DNA is degraded or low in con-
centration, so the analysis cannot determine that a novel
or unsequenced organism is present. Therefore, users of
the MDA will need to interpret the data in the context
of what else is known about the sample, to determine
whether the predicted organisms are exact matches to
known species or are novel but with some similarity to
other sequenced microbes. Highly novel targets with no
similarity to genomes in the database or probes on the
array will not be detected. The failure of the MDA to
detect VSV NJ in pure culture illustrates this well, and
highlights a shortcoming of our approach to use only
complete genomes to design the array. Future versions
of the array will include all available sequence data,
including partial sequences and gene fragments, for spe-
cies lacking complete genomes. Modified statistical algo-
rithms will then be required to deal with sequence
length bias when partial genomes are included in the
database. Most importantly, as new sequence data
becomes available from newly discovered or newly
sequenced organisms, the MDA must be updated with
probes to detect them. We are currently designing Ver-
sion 3 of the MDA to address these issues, probing both
partial and complete bacterial and viral sequences, as
well as fungi and some protozoa.
Conclusions
The MDA is a tool to identify viral and bacterial organ-
isms present in simple or complex samples. We have
demonstrated the capability of the array and our statisti-
cal methods to identify multiple bacteria and viruses in
clinical samples and verified results with PCR.
Gardner et al. BMC Genomics 2010, 11:668
http://www.biomedcentral.com/1471-2164/11/668
Page 16 of 21Improvements are suggested for the design of future
detection arrays, and continued updates to incorporate
probes for newly sequenced microbes will be required.
Methods
Probe design for family level characterization
Figure 1 summarizes our array design process. We
downloaded all complete genomes, segments, and plas-
mid sequences, organized by family, for all bacteria and
viruses, from NCBI Genbank, Integrated Microbial
Genomics (IMG) project at the Joint Genome Institute,
The Comprehensive Microbial Resource (CMR) at the
JC Venter Institute, and The Sanger Institute in the
United Kingdom, with some additional proprietary
whole-genome data from collaborators. We included
only bacteria under the superkingdom Bacteria (eubac-
teria) taxonomy node at NCBI, and did not include the
Archaea. Sequence data was current as of the time that
probe design began for a given probe set: 34,625 viral
target sequences on April 25, 2007 (viral probes, v.1),
38,402 viral target sequences on October 29, 2007 (viral
probes, v.2), and 3,477 bacterial target sequences on July
12, 2007 (bacterial probes, v.2). These represented 2195
viral species and 924 bacterial species.
Probes were selected from whole genomes, without
regard to gene locations or identities, letting the
sequences themselves determine the best signature
regions and preclude bias by pre-selection of genes. In
prior work, we have found that the length of longest
perfect match (PM) is a strong predictor of hybridiza-
tion intensity, and that for probes at least 50 nt long,
PM ≤ 20 bp have signal less than 20% of that with a
perfect match over the entire length of the probe. [2]
This is similar to results from a systematic study of viral
probe hybridization characteristics by [7]. Therefore, for
each target family we eliminated regions with perfect
matches to sequences outside the target family. Using the
suffix array software Vmatch [26], perfect match subse-
quences of at least 17 nt long present in non-target viral
families or 25 nt long present in the human genome or
nontarget bacterial families were eliminated from consid-
eration as possible probe subsequences. Sequence simi-
larity of probes to non-target sequences below this
threshold was allowed, but could be accounted for using
the statistical algorithm described below.
From these family-specific regions, we designed probes
50-66 bases long for one family at a time using the
methods described in [2]. Probes were sufficiently long
(50-66 bases) to tolerate some sequence variation,
although slightly shorter than the 70-mer probes used
on previous arrays [4,11,12] because of the additional
synthesis cycles, and therefore cost, of making 70-mers
on the NimbleGen platform. Long probes improve
hybridization sensitivity and efficiency, alleviate
sequence-dependent variation in hybridization, and
improve the capability to detect unsequenced microbes.
Quantifying the microbe load was not a goal of this
array; sensitive detection of microbe presence was the
aim, facilitated by the higher sensitivity of longer probes.
As in [2], we generated candidate probes using MIT’s
Primer3 software [27], followed by Tm and homodimer,
hairpin, and probe-target free energy (ΔG) prediction
using Unafold [28]. Candidate probes with unsuitable
ΔG’so rT m’s were excluded as described in [2]. Desir-
able range for these parameters was 50 ≤ length ≤ 66,
Tm≥80°C, 25% ≤ GC% ≤ 75%, ΔGhomodimer = ΔGo f
homodimer formation > 15 kcal/mol, ΔGhairpin = ΔGo f
hairpin formation > -11 kcal/mol, and ΔGadjusted =
ΔGcomplement -1 . 4 5ΔGhairpin -0 . 3 3ΔGhomodimer ≤ -52
kcal/mol. For the v2 array design, which includes bacter-
ial probes, an additional minimum sequence complexity
constraint was enforced, requiring a trimer frequency
entropy of at least 4.5 (calculation described below). If
fewer than a minimum number of candidate probes per
target sequence passed all the criteria, then those cri-
teria were relaxed to allow a sufficient number of probes
per target. To relax the criteria, first candidates that passed
the Primer3 criteria but failed the Unafold filters were
allowed. If no candidates passed the Primer3 criteria, then
regions passing the target-specificity (e.g. family specific)
and minimum length constraints were allowed. From
these candidates, we selected probes in decreasing order of
the number of targets represented by that probe (i.e.
probes detecting more targets in the family were chosen
preferentially over those that detected fewer targets in the
family), where a target was considered to be represented if
a probe matched it with at least 85% sequence similarity
over the total probe length, and a perfectly matching sub-
sequence of at least 29 contiguous bases spanned the mid-
dle of the probe. For probes that tied in the number of
targets represented, a secondary ranking was used to favor
probes most dispersed across the target from those probes
which had already been selected to represent that target.
The probe with the same conservation rank that occurred
at the farthest distance from any probe already selected
from the target sequence was the next probe to be chosen
to represent that target.
The MDA v.1 array contained probes representing all
complete viral genomes or segments associated with a
known viral family, with at least 15 probes per target
(Table 4). It did not include unclassified targets not
designated under a family. On the v.2 array, every viral
genome or segment was represented by at least 50
probes, totaling 170,399 probes, except for 1,084 viral
genomes that were not associated under a family-ranked
taxonomic node ("nonConforming sequences”). These
had a minimum of 40 probes per sequence totaling
12,342 probes. There were a minimum of 15 probes per
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Page 17 of 21bacterial genome or plasmid sequence, totaling 7,864
probes on the v.2 array. Bacterial genomes that were not
associated under a family-ranked taxonomic node were
not included in the array design.
On both MDA v.1 and v.2, as controls for the presence of
human DNA/mRNA from clinical samples, we designed
1,278 probes to human immune response genes. For tar-
gets, the genes for GO:0009615 ("response to virus”) were
d o w n l o a d e df r o mt h eG e n eO n t o l o g yA m i G Ow e b s i t e
http://amigo.geneontology.org, filtering for Homo sapien
sequences. There were 58 protein sequences available at the
time (July 12, 2007), and from these, the gene sequences of
length up to 4× the protein length were downloaded from
the NCBI nucleotide database based on the EMBL ID num-
ber, resulting in 187 gene sequences. Fifteen probes per
sequence were designed for these using the same specifica-
tions as for the bacterial and viral target probes.
We designed ~2,600 random control sequences that
were length and GC% matched to the target probes on
MDA v.1 or v.2. These had no appreciable homology to
known sequences based on BLAST similarity, and were
used to assess background hybridization intensity. These
were designed by calculating the fraction f(L, g) of detec-
tion probes with length = L and GC% = g, and simulating
f(L, g) times the number of random probes desired ran-
dom sequences of length L and GC% g for each L, g
observed in the detection probes. In addition, we also
included on the v.1 and v.2 arrays the 21,888 probes from
the ViroChip version 3 from University of California San
Francisco [4,14,24,29] downloaded from http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GPL3429. We note
that additional probe sets may be added to meet unique
needs of specific customers, not discussed further here.
Sample preparation and microarray hybridization
DNA microarrays were synthesized using the Nimble-
Gen Maskless Array Synthesizer at Lawrence Livermore
National Laboratory as described [2]. Adenovirus type 7
strain Gomen (Adenoviridae), respiratory syncytial virus
(RSV) strain Long (Paramyxoviridae), respiratory syncy-
tial virus strain B1, bluetongue virus (BTV) type 2 (Reo-
viridae) and bovine viral diarrhea virus (BVDV) strain
Singer (Flaviviridae) were p u r c h a s e df r o mt h eN a t i o n a l
Veterinary lab and grown at our laboratory. Purified
DNA from human herpesvirus 6B (HHV6B) (Herpesviri-
dae) and vaccinia virus strain Lister (Poxviridae) were
purchased from Advanced Biotechnologies (Maryland,
VA). 11 blinded viral culture samples were received
from Dr. Robert Tesh’s lab at University of Texas Medi-
cal Branch at Galveston (UTMB). The viral cultures
were sent to LLNL in the presence of Trizol reagent.
After treatment with Trizol reagent, RNA from cells was
precipitated with isopropanol and washed with 70% etha-
nol. The RNA pellet was dried and reconstituted with
RNase free water. 1 μg of RNA was transcribed into dou-
ble-strand cDNA with random hexamers using Super-
script™ double-stranded cDNA synthesis kit from
Invitrogen (Carlsbad, CA). The DNA or cDNA was
labeled using Cy-3 labeled nonamers from Trilink Bio-
technologies and 4 μg of labeled sample was hybridized to
the microarray for 16 hours as previously described (Jaing
et al., 2008). Clinical samples that had been extracted and
partially purified using Round A and Round B protocols
(Wang et al, 2003) were obtained from Dr. Joseph DeRisi’s
laboratory at University of California, San Francisco
(UCSF). The samples were amplified for an additional 15
cycles to incorporate aminoallyl-dUTP and labeled with
Cy3NHS ester (GE Healthcare, Piscataway, NJ). The
labeled samples were hybridized to NimbleGen arrays.
Data have being submitted to the Gene Expression
Omnibus (GEO) database http://www.ncbi.nlm.nih.gov/
geo/ accession number GSE24700.
PCR for confirmation
Clinical samples from the DeRisi laboratory were tested
by PCR to confirm the microarray results. PCR primers
Table 4 Summary of array design: Probe counts
Number of Probes Probe Description
Version 1
36497 Viral detection probes (15 probes/seq from each taxonomic family)
20736 ViroChip probes
1278 human viral response genes
3000 random controls
Version 2
170399 Viral probes (50 probes/seq from each taxonomic family) × 2 replicates
12342 nonConforming viruses (not associated w/ taxonomic family, 40 probes/seq)
7864 bacterial probes (15/seq)
20736 ViroChip probes
1278 human viral response genes
2651 random controls
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Page 18 of 21were designed using either the KPATH system [30] or
based on the probes that gave a positive signal for the
organism identified as present, and the primer
sequences are proved as Additional file 1. PCR primers
were synthesized by Biosearch Technologies Inc
(Novato, CA). 1 μL of Round B material was re-ampli-
fied for 25 cycles and 2 μLo ft h eP C Rp r o d u c tw a s
used in a subsequent PCR reaction containing Platinum
Taq polymerase (Invitrogen), 200 mM primers for
35 cycles. The PCR condition is as follows: 96°C, 17 sec,
60°C, 30 sec and 72°C, 40 sec. The PCR products were
visualized by running on a 3% agarose gel in the pre-
sence of ethidium bromide.
Statistical analysis
For each array hybridization, we transformed the probe
intensities Iik (for probe i on an array hybridized to sam-
ple k)t ob i n a r yv a l u e sYik,r e p r e s e n t i n gw h e t h e rIik
exceeds an array-specific detection threshold. The
threshold was typically calculated as the 99
th percentile
of the intensities of the negative control probes.
We developed simple logistic models to predict two
conditional probabilities: the probability of observing
Yik = 1 given the presence of a specific microbial target
in sample k, and the probability of observing Yik =1
given no complementary targets. The predictors for the
specific probability P(Yik =1|t a r g e tj is present) were
derived by BLASTing probe i’ss e q u e n c ea g a i n s tt a r g e t
j’s genome, with an E-value threshold of 0.1, and choos-
ing the highest scoring alignment for the probe-target
pair. The BLAST bit score Bij and the probe alignment
start position Qij were extracted directly from the
BLAST output; the melting temperature Tij was com-
puted according to the formula Tij = 69.4°C + (41 NGC -
600)/L,w h e r eL is the length of the alignment and NGC
is the number of G or C bases in the alignment.
The entropy Si of the probe sequence trimer distribu-
tion was computed by counting the numbers of occur-
rences nAAA,n AAC,. . . ,n TTT of the 64 possible trimers in
the probe sequence, and dividing by the total number of
trimers, yielding the corresponding frequencies fAAA,. . . ,
fTTT. The entropy is then given by:
Sf f it t
tf t
=−
≠ ∑  log2
:0
where the sum is over the trimers t with ft ≠ 0. We
estimate the nonspecific signal probability with a logistic
model:
PY
aa S
ik
i
(| )
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=
=
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We then model the specific probe signal probability by
a logistic function in which the linear predictor com-
bines both nonspecific and target-specific terms:
PY j
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=
+− + + + +
1
1
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target   present
i ij)]
To fit the parameters a0 through a4 in the above mod-
els, we ran array experiments using samples of viruses
and bacteria with known genome sequences, computed
the covariates Si,T ij,B ij,a n dQij, and performed logistic
regression against the observed outcomes.
To apply this model to samples containing unknown
targets, we performed an exhaustive BLAST search for
e v e r yp r o b eo nt h ea r r a ya g a i n s tac o m p r e h e n s i v ed a t a -
base of complete microbial genome sequences. We then
computed the covariates Bij,T ij,a n dQij for each target
on the array, for all probes having significant BLAST
hits (E-value < 0.1) against the target.
The conditional probe signal probabilities are then
combined to compute a likelihood function for the pre-
sence of a particular target, given the observed probe
s i g n a l so na na r r a y .I nt h el i k e l i h o o df u n c t i o n ,w e
assume that the probe signals are independent of one
another, conditioned on the sample composition. Let X
=( X1,X 2,. . . ,X m) be a vector of target presence indica-
tors, where Xj = 1 if target j is present and 0 if not. The
conditional likelihood of Xj given the observed data Y
can then be written:
LX Y
PY X PY X
j
ij
iY
ij
iY ii
(; )
(| )(| )
::
=
==
== ∏∏ 10
10
(4)
where the individual probe-target signal probabilities
are given by:
PY X
e
ij
a aS X aT aB aQ i j ij ij ij
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(5)
When multiple targets may be present, an approxima-
tion is used to compute the probe signal probabilities:
PY X PY X
e
ii j
jX
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j
ii ji j
(| ) (| )
:
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Here we assume that the probability of obtaining a
negative signal for a probe depends only on the set of
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Page 19 of 21targets that are assumed to be present, and that we can
estimate the probability by multiplying the probabilities
conditioned on the presence of the individual targets.
To find a combination of target presence indicators
X that best explains the observed data, we use a greedy
algorithm to find a local maximum for the log-likelihood.
The algorithm is initialized by placing all candidate tar-
gets in an “unselected” list U, and creating an empty
“selected” list S. The following steps are then iterated
until the algorithm terminates:
1. Compute the conditional log-odds score lj for each
target j Î U:
j
ij k
ijk iY
PY X X k S
PY X X k S
i
=
=== ∀ ∈
=== ∀ ∈
+
= ∑ log 
l
(| , )
(| , )
:
111
101
1
o og 
PY X X k S
PY X X k S
ij k
ij k iY i
(|, )
(| , )
:
== = ∀ ∈
=== ∀ ∈
= ∑
011
001
0
lj is the log of the ratio of the likelihood of the data, if
target j is added to S, to its likelihood if j is not added.
When this step is performed for the first time, the
selected list S will be empty, so the computed log-odds
score for target j will not be conditioned on the
presence of any other targets. We store this “initial” log-
odds score lj
(i) for later display.
2. Choose the target j that yields the largest value of
lj, remove it from list U, and add it to the end of list S.
We store the value of this “final” score lj
(f) for each tar-
get in S.
3. Repeat steps 1 and 2 until there is no target in U
that yields a positive value for the conditional log-odds
score (i.e., that increases the log-likelihood).
The result of this analysis is an ordered series S of tar-
get genomes predicted to be present, together with a
pair of scores for each target in S. The initial score lj
(i)
is its log-odds from the first iteration; that is, the log of
t h er a t i oo ft h el i k e l i h o o dw i t ht a r g e tj present to the
likelihood with no targets present. The final score lj
(f) is
the contribution of target j to the log likelihood at the
time that it was selected, assuming the presence of all
the targets that were selected prior to j.
The analysis algorithm is implemented in the Python
language, except for plotting which is performed using
the R programming environment. The software is avail-
able on request from the authors.
Additional material
Additional file 1: Primer sequences and product sizes used to
confirm the array results from clinical samples.
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